Best Small-Cap Cannabis Stocks
Updated March 2026Small-cap cannabis stocks with market caps under $200 million. Emerging operators and niche players ranked by market cap.
Small-cap cannabis stocks — those with market capitalizations under $200 million — represent the emerging operators, niche specialists, and early-stage companies in the marijuana industry. While they carry more risk than their larger counterparts, small-caps also offer the greatest potential for outsized returns if they can execute their business plans and grow into mid- or large-cap companies over time.
The small-cap tier of cannabis includes a diverse group: single-state MSOs expanding within their home markets, specialty cultivators focused on premium flower, technology startups serving the cannabis industry, early-stage biotechs developing cannabinoid therapies, and international operators building businesses in emerging legal markets. Many of today's large-cap cannabis companies were small-caps just a few years ago, demonstrating the growth potential (and volatility) inherent in this space.
Small-cap cannabis stocks are typically less liquid, less covered by analysts, and more volatile than large-caps. But for investors willing to do their own research and accept higher risk, this segment of the market can offer the most compelling risk-reward profiles — particularly when broader sector sentiment is negative and small-caps are trading at deep discounts to intrinsic value.
Best Small-Cap Cannabis Stocks — Full Rankings
30 stocks · Ranked by market cap
| # | Ticker | Name | Price | Change | Market Cap | Revenue | Margin | P/S | Market Cap |
|---|---|---|---|---|---|---|---|---|---|
| 1 | ACB | Aurora Cannabis | $3.43 | -3.65% | $194.5M | $0 | — | — | $194.5M |
| 2 | OGI | Organigram Holdings | $1.41 | -2.76% | $190.6M | $0 | — | — | $190.6M |
| 3 | GDNSF | Vireo Growth (Goodness Growth) | $0.44 | -1.12% | $182.2M | $0 | — | — | $182.2M |
| 4 | MJ | ETFMG Alternative Harvest ETF | $24.79 | +0.74% | $123.1M | $0 | — | — | $123.1M |
| 5 | CBWTF | Auxly Cannabis Group | $0.09 | +1.07% | $111.6M | $0 | — | — | $111.6M |
| 6 | CWBHF | Charlotte's Web Holdings | $0.62 | -0.22% | $99.3M | $0 | — | — | $99.3M |
| 7 | JUSHF | Jushi Holdings | $0.49 | -0.26% | $96.4M | $0 | — | — | $96.4M |
| 8 | AGFY | Agrify Corp | $47.12 | +4.71% | $94.2M | $15.4M | 75.5% | 6.12x | $94.2M |
| 9 | LOVFF | Cannara Biotech | $1.30 | -5.09% | $81.9M | $0 | — | — | $81.9M |
| 10 | CNBS | Amplify Seymour Cannabis ETF | $23.50 | +1.95% | $77.3M | $0 | — | — | $77.3M |
| 11 | MAPS | WM Technology (Weedmaps) | $0.68 | -7.27% | $73.0M | $174.7M | 94.9% | 0.42x | $73.0M |
| 12 | HEXO | HEXO Corp | $0.71 | +5.62% | $68.9M | $0 | — | — | $68.9M |
| 13 | FORA | Forian Inc | $2.05 | -0.97% | $63.7M | $28.1M | 51.6% | 2.27x | $63.7M |
| 14 | GRWG | GrowGeneration | $1.06 | -2.75% | $63.4M | $161.4M | 27.2% | 0.39x | $63.4M |
| 15 | AFCG | AFC Gamma (Advanced Flower Capital) | $2.63 | +0.38% | $61.9M | $24.6M | — | 2.52x | $61.9M |
| 16 | CNVCF | BioHarvest Sciences | $5.71 | +1.33% | $57.1M | $0 | — | — | $57.1M |
| 17 | NVACF | Nova Cannabis | $1.26 | -0.47% | $50.6M | $0 | — | — | $50.6M |
| 18 | AAWH | Ascend Wellness Holdings | $0.49 | -0.89% | $47.0M | $0 | — | — | $47.0M |
| 19 | GRAMF | TPCO Holding (The Parent Company) | $0.16 | -12.99% | $45.7M | $0 | — | — | $45.7M |
| 20 | DBCCF | Decibel Cannabis Co | $0.09 | +7.20% | $36.1M | $0 | — | — | $36.1M |
| 21 | VEXTF | Vext Science | $0.19 | 0.00% | $34.2M | $0 | — | — | $34.2M |
| 22 | ZYNE | Zynerba Pharmaceuticals | $1.30 | +3.17% | $33.8M | $0 | — | — | $33.8M |
| 23 | CXXIF | C21 Investments | $0.28 | +3.61% | $33.5M | $0 | — | — | $33.5M |
| 24 | THCX | Cannabis ETF | $16.60 | -0.26% | $33.2M | $0 | — | — | $33.2M |
| 25 | YOLO | AdvisorShares Pure Cannabis ETF | $2.83 | -4.88% | $33.1M | $0 | — | — | $33.1M |
| 26 | MRMD | MariMed Inc | $0.08 | +8.14% | $32.3M | $0 | — | — | $32.3M |
| 27 | ETST | Earth Science Tech | $0.11 | -5.17% | $32.2M | $0 | — | — | $32.2M |
| 28 | AVTBF | Avant Brands | $0.52 | +3.82% | $28.6M | $0 | — | — | $28.6M |
| 29 | ITHUF | iAnthus Capital Holdings | $0.00 | -11.82% | $26.1M | $0 | — | — | $26.1M |
| 30 | HMLSF | Global X Marijuana Life Sciences ETF | $5.21 | 0.00% | $26.1M | $0 | — | — | $26.1M |
Top 3 Spotlight
Aurora Cannabis
Aurora Cannabis ranks #1 in the best small-cap cannabis stocks category with a share price of $3.43 and a market capitalization of $194.5M. The company operates in the LP sector and is listed on the NASDAQ. With trailing twelve-month revenue of $0 and a gross margin of N/A, ACB represents the top-ranked stock in this category based on market cap.
Organigram Holdings
Organigram Holdings ranks #2 in the best small-cap cannabis stocks category with a share price of $1.41 and a market capitalization of $190.6M. The company operates in the LP sector and is listed on the NASDAQ. With trailing twelve-month revenue of $0 and a gross margin of N/A, OGI represents the second-ranked stock in this category based on market cap.
Vireo Growth (Goodness Growth)
Vireo Growth (Goodness Growth) ranks #3 in the best small-cap cannabis stocks category with a share price of $0.44 and a market capitalization of $182.2M. The company operates in the MSO sector and is listed on the OTC. With trailing twelve-month revenue of $0 and a gross margin of N/A, GDNSF represents the third-ranked stock in this category based on market cap.
Methodology
Stocks are filtered to include only companies with positive market capitalization below $200 million and ranked in descending order by market cap, showing the largest small-caps first. Data is sourced from company filings, exchange feeds, and financial data providers. Rankings update automatically as new data becomes available. All financial figures are based on trailing twelve-month (TTM) data unless otherwise noted. The current ranking includes 30 qualifying stocks out of 100 total cannabis companies tracked by Cannabismarketcap.
Key Observations
The top-ranked stock in the best small-cap cannabis stocks category is ACB (Aurora Cannabis) with a market cap of $194.5M. The stock trades at $3.43 per share with a market capitalization of $194.5M. In second place is OGI ($190.6M), followed by GDNSF ($182.2M) in third.
Across all 30 qualifying stocks, the average share price is $4.84 and the average market capitalization is $71.1M. The combined trailing twelve-month revenue of all companies in this category is $404.1M. The average gross margin among companies with positive margins is 62.3%. The average price-to-sales ratio is 2.34x.
The most represented sector in this category is LP with 8 out of 30 companies (27%). Among the ranked stocks, 12 are trading higher today while 16 are trading lower. Investors should use these observations as a starting point for further research rather than as the basis for trading decisions.
Investment Considerations
When evaluating stocks in the best small-cap cannabis stocks category, consider looking beyond the primary ranking metric to build a holistic view of each company. A stock that ranks well by market cap may have weaknesses in other areas — such as high debt, poor margins, or slowing growth — that the ranking alone does not capture. Cross-reference this list with other Cannabismarketcap category pages and the screener tool to identify stocks that score well across multiple dimensions.
Position sizing is particularly important in cannabis. The sector is inherently volatile, and even the strongest companies can experience 30-50% drawdowns during sector-wide sell-offs triggered by legislative disappointments or broader market risk-off events. Most financial advisors suggest limiting total cannabis exposure to 5-15% of your portfolio, and individual positions to 1-3% depending on your risk tolerance and conviction level.
Dollar-cost averaging (DCA) is a widely recommended approach for building cannabis stock positions over time. Rather than investing your entire allocation at a single price point, spreading purchases across weeks or months can reduce the impact of short-term volatility and lower your average cost basis if prices decline after your initial purchase. This strategy is particularly relevant for the stocks in this category given the sector's history of sharp and sometimes prolonged drawdowns.
Risk Factors
Risk Warning
Small-cap cannabis stocks carry elevated risk across multiple dimensions. Liquidity is often poor, with wide bid-ask spreads and low daily trading volumes that can make it difficult to enter or exit positions at desired prices. Many small-cap cannabis companies are not profitable, have limited cash runways, and may need to raise capital through dilutive equity offerings at unfavorable prices. Analyst coverage is minimal to nonexistent, meaning material information may not be widely disseminated. Small companies are also more vulnerable to management risk — the departure of a key executive or founder can significantly impact operations. Finally, in a sector downturn, small-caps typically experience the steepest declines and the slowest recoveries because institutional investors retreat to larger, more liquid names first.
Compare These Stocks
Head-to-head comparisons between top-ranked stocks in this category.
Frequently Asked Questions
What is considered small-cap in the cannabis industry?
On CannaCap, we define small-cap cannabis stocks as those with market capitalizations under $200 million. This threshold captures companies that are established enough to be publicly traded but have not yet achieved the scale of the sector's leaders. For context, in the broader stock market, small-cap typically refers to companies between $300 million and $2 billion — but because the entire cannabis sector is much smaller, the thresholds are proportionally lower. Some analysts define cannabis small-cap as under $100 million and mid-cap as $100-500 million.
Why should I consider investing in small-cap cannabis stocks?
Small-cap cannabis stocks offer the potential for outsized returns that are difficult to achieve with larger, more established companies. A $50M market cap company that executes well and grows to $500M delivers a 10x return — a magnitude of return that is essentially impossible for a company already valued at $5 billion. Small-caps are also less followed by analysts and institutions, creating potential for mispricing that diligent individual investors can exploit. However, this potential upside comes with correspondingly higher risk, and a significant percentage of small-cap cannabis companies will underperform or fail entirely.
How should I size positions in small-cap cannabis stocks?
Position sizing should be inversely proportional to risk. For small-cap cannabis stocks, most financial advisors would suggest limiting individual positions to 1-3% of your total portfolio. Within a dedicated cannabis allocation, you might spread capital across 10-15 small-caps rather than concentrating in just one or two names. This portfolio approach recognizes that while any individual small-cap has a meaningful probability of significant decline, a diversified basket of small-caps has a reasonable probability of capturing at least one or two large winners that offset the losers.
What due diligence should I perform on small-cap cannabis stocks?
For small-cap cannabis companies, prioritize these research areas: (1) Financial runway — does the company have enough cash to operate for at least 12 months without raising capital? (2) Revenue trend — is revenue growing, stable, or declining over the past 3-4 quarters? (3) Insider activity — are executives buying or selling shares? (4) Share dilution — has the share count increased significantly over the past year? (5) Competitive position — does the company have licenses, brands, or technology that provide a defensible advantage? (6) Management track record — does leadership have relevant industry experience? (7) Auditor quality — does a reputable firm audit the financials?
More on Cannabismarketcap
Disclaimer: The information on this page is for informational and educational purposes only and does not constitute investment advice, a recommendation, or a solicitation to buy or sell any security. Cannabis stocks are highly speculative and carry significant risk of loss, including the potential loss of your entire investment. Past performance is not indicative of future results. The rankings and data presented are based on publicly available financial information and may contain errors or omissions. Always do your own research and consult with a qualified financial advisor before making investment decisions. Cannabismarketcap is not a registered investment advisor, broker-dealer, or financial planner.